Invesco »

Eliem Therapeutics shares owned by Invesco

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Invesco from 13F filings

Historical chart of Invesco investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Invesco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Invesco

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.9M 373k 13.04

More positions owned by Invesco

NVIDIA Corporation (NVDA)
Apple (AAPL)
Micron Technology (MU)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Advanced Micro Devices (AMD)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Lam Research Corp Com New (LRCX)
Intel Corporation (INTC)
Meta Platforms Cl A (META)
Applied Materials (AMAT)
Wal-Mart Stores (WMT)

View all positions for Invesco

Top funds holding Eliem Therapeutics

RA Capital Management
FMR
UBS Group
Braidwell
Adage Capital Partners GP
BlackRock
Cormorant Asset Management
Frontier Capital Management
T. Rowe Price Associates
Vanguard Capital Management
Woodline Partners
Citadel Advisors
Redmile Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors

View all funds holding Eliem Therapeutics